Impact of respiratory viral infections on cystic fibrosis

D Wat, D Wat

Abstract

The life expectancy for patients with cystic fibrosis has improved remarkably over the last 20 years. Progressive deterioration of pulmonary function continues despite the aggressive use of antimicrobials. The absence of fever, neutrophilia, and systemic symptoms suggest that during pulmonary exacerbations other non-bacterial factors may have played a part. Some have suggested respiratory viruses as main suspects. So far, few data have illustrated the relationship of respiratory viruses and cystic fibrosis. By gaining further knowledge of this relationship, one may change future clinical practice and boost the survival of these patients.

References

    1. Int J Antimicrob Agents. 2001 Feb;17(2):93-6
    1. Am J Epidemiol. 1969 Apr;89(4):422-34
    1. J Infect Dis. 1976 Aug;134(2):144-9
    1. J Infect Dis. 1976 Dec;134(6):552-61
    1. Acta Paediatr Scand. 1981 Sep;70(5):623-8
    1. Ann Intern Med. 1984 Jun;100(6):795-800
    1. N Engl J Med. 1984 Dec 27;311(26):1653-8
    1. J Pediatr. 1988 Nov;113(5):826-30
    1. Am J Dis Child. 1989 Jun;143(6):662-8
    1. Science. 1989 Sep 8;245(4922):1066-73
    1. Pediatr Pulmonol Suppl. 1991;7:42-5
    1. Thorax. 1991 Dec;46(12):881-5
    1. J Med Virol. 1993 Jun;40(2):96-101
    1. J Cell Sci Suppl. 1993;17:229-33
    1. BMJ. 1995 May 13;310(6989):1225-9
    1. Arch Dis Child. 1995 Aug;73(2):117-20
    1. Thorax. 1996 Nov;51(11):1115-22
    1. Clin Diagn Virol. 1997 May;8(1):31-40
    1. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1197-204
    1. BMJ. 1998 Jun 13;316(7147):1771-5
    1. N Engl J Med. 1999 Jan 7;340(1):23-30
    1. Pediatr Pulmonol. 1998 Dec;26(6):371-9
    1. Clin Microbiol Rev. 1999 Jan;12(1):9-18
    1. J Clin Virol. 1999 Aug;13(3):131-9

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner